Manufacturer:

Eagle Pharmaceuticals

Name:

BELRAPZO

Category:

J Code

HCPCS:

J9036

NDC(s):

10019-0079-01, 42367-0520-25, 42367-0521-25,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

BELRAPZO is a Cancer drug manufactured by Eagle Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9036 is aligned to the drug BELRAPZO.